Evidence map›Paper›PMID 42683040›Full record

ArticleIranian journal of basic medical sciences2026

Synergistic myelin regenerative, immunomodulatory and anti-inflammatory effects of vanillin and adipose derived stem cells in cuprizone animal model of multiple sclerosis.

Sara Gazmeh, Mohammad Mardani, Nazem Ghasemi

Abstract read
In one paragraph

Article in Iranian journal of basic medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sara GazmehDepartment of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammad MardaniDepartment of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Nazem GhasemiDepartment of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Vanillin as a potential therapeutic agent along with transplantation of neurotrophic factors secreting cells, is considered a promising treatment for neurological disorders. In this study, the effects of vanillin in combination with human adipose derived stem cells transplantation were evaluated on oligodendrocyte differentiation, re-myelination, and motor function improvement. Materials and Methods: Female C57BL/6 mice were fed cuprizone (400 mg/kg/day) for 5 weeks to induce MS. Demyelinated mice were divided into MS, MS/vanillin, MS/stem cells, and MS/vanillin/stem cells groups. Additionally, sixteen mice were divided into control and sham groups for comparison. Motor function was assessed using the hanging wire test. Finally, serum levels of inflammatory (IL-2, IFN-γ) and anti-inflammatory (IL-10, TGF-β) factors, along with IgG, were measured by ELISA. The mean percentage of Olig2 and MOG-positive cells we determined using the immunohistochemical technique, and Luxal Fast Blue staining was performed to assess myelin density of corpus callosum. Results: The results revealed that the mean percentage of Olig2, Mog positive cells, the serum level of the IL-10 and TGF-β, myelin density, and behavior test score were significantly higher in treated groups specially in MS/vanillin/stem cells group ( Conclusion: Administration of vanillin with stem cell transplantation could be a suitable approach to accelerate the process of myelin repair in the nervous tissue.

Indexed as

Adipose derived stem cellsMultiple sclerosisMyelinOligodendrocyteVanillin

Identifiers

PMID42683040
PMCPMC13531677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.